NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 289 filers reported holding NEOGENOMICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $414,254 | -41.7% | 25,851 | -66.4% | 0.00% | -40.0% |
Q4 2022 | $710,329 | -16.1% | 76,879 | -21.8% | 0.01% | -16.7% |
Q3 2022 | $847,000 | -90.7% | 98,316 | -63.3% | 0.01% | -89.7% |
Q4 2021 | $9,151,000 | -27.1% | 268,194 | +3.1% | 0.06% | -31.8% |
Q3 2021 | $12,548,000 | +48.3% | 260,120 | +38.9% | 0.08% | +46.6% |
Q2 2021 | $8,462,000 | -44.8% | 187,332 | -36.8% | 0.06% | -54.7% |
Q1 2021 | $15,335,000 | -4.0% | 296,519 | -0.0% | 0.13% | +1.6% |
Q4 2020 | $15,966,000 | +1137.7% | 296,528 | +747.6% | 0.13% | +950.0% |
Q3 2020 | $1,290,000 | -92.6% | 34,983 | -93.8% | 0.01% | -93.5% |
Q2 2020 | $17,415,000 | +30.5% | 562,098 | +20.5% | 0.18% | +24.3% |
Q1 2020 | $13,343,000 | -2.2% | 466,665 | +0.0% | 0.15% | +1.4% |
Q4 2019 | $13,648,000 | +174.3% | 466,584 | +79.3% | 0.15% | +121.2% |
Q3 2019 | $4,975,000 | +29.3% | 260,201 | +47.7% | 0.07% | +37.5% |
Q2 2019 | $3,849,000 | +41.2% | 176,201 | +32.3% | 0.05% | +37.1% |
Q1 2019 | $2,725,000 | – | 133,201 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |